HEART FAILURE WITH REDUCED EJECTION FRACTION (HFREF)
Clinical trials for HEART FAILURE WITH REDUCED EJECTION FRACTION (HFREF) explained in plain language.
Never miss a new study
Get alerted when new HEART FAILURE WITH REDUCED EJECTION FRACTION (HFREF) trials appear
Sign up with your email to follow new studies for HEART FAILURE WITH REDUCED EJECTION FRACTION (HFREF), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Remote monitoring may Fine-Tune heart failure meds faster
Disease control Recruiting nowThis study tests whether telemedicine follow-up helps doctors adjust heart failure medications more effectively than standard in-person visits. Eighty adults with newly diagnosed heart failure with reduced ejection fraction will be randomly assigned to either remote monitoring or…
Matched conditions: HEART FAILURE WITH REDUCED EJECTION FRACTION (HFREF)
Phase: NA • Sponsor: Azienda Unita Sanitaria Locale di Piacenza • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Smart watch for the heart: can remote monitoring save lives?
Disease control Recruiting nowThis study tests a new remote monitoring system called SmartSignalHF in 1132 adults with heart failure who have an implanted heart device (ICD or CRT-D). The goal is to see if this system can reduce deaths and hospital stays over 12 months compared to standard care. Participants …
Matched conditions: HEART FAILURE WITH REDUCED EJECTION FRACTION (HFREF)
Phase: NA • Sponsor: Implicity • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New drug shows promise for repairing damaged hearts in stable heart failure patients
Disease control Recruiting nowThis study looks at whether the drug vericiguat can help repair the hearts of adults with stable heart failure with reduced ejection fraction (HFrEF). Researchers will compare people taking vericiguat plus standard care to those on standard care alone, measuring changes in heart …
Matched conditions: HEART FAILURE WITH REDUCED EJECTION FRACTION (HFREF)
Phase: PHASE4 • Sponsor: University Medical Centre Ljubljana • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Does timing of blood pressure med matter for kidney protection? new trial investigates
Disease control Recruiting nowThis phase 4 trial tests whether taking ramipril once daily or split into two smaller doses works better for protecting kidney function in 80 adults with chronic kidney disease and heart failure. Over 30 days, researchers will measure changes in blood markers of kidney function, …
Matched conditions: HEART FAILURE WITH REDUCED EJECTION FRACTION (HFREF)
Phase: PHASE4 • Sponsor: Evi Liliek Wulandari • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Can a simple ultrasound predict the best pacemaker for heart failure?
Disease control Recruiting nowThis study looks at 100 people with heart failure who need a special pacemaker. Doctors want to see if a heart ultrasound before the procedure can predict which pacing method—left bundle branch pacing or standard biventricular pacing—works better. The goal is to improve how well …
Matched conditions: HEART FAILURE WITH REDUCED EJECTION FRACTION (HFREF)
Phase: NA • Sponsor: University Hospital of Patras • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
Heart drug showdown: which Beta-Blocker best protects ICD patients?
Disease control Recruiting nowThis study compares two common heart failure medications, carvedilol and metoprolol succinate, in 2,000 adults who have an implantable cardioverter defibrillator (ICD). Participants currently taking metoprolol will be randomly assigned to either stay on it or switch to carvedilol…
Matched conditions: HEART FAILURE WITH REDUCED EJECTION FRACTION (HFREF)
Phase: PHASE4 • Sponsor: University of Rochester • Aim: Disease control
Last updated Jun 26, 2026 18:20 UTC
-
Smart watch study aims to cut heart failure hospitalizations by 20%
Knowledge-focused Recruiting nowThis study is testing whether a special wearable device, combined with artificial intelligence, can help people with chronic heart failure avoid hospital visits. About 205 adults will wear the device for six months while their health data is monitored remotely. The goal is to see…
Matched conditions: HEART FAILURE WITH REDUCED EJECTION FRACTION (HFREF)
Sponsor: University of Salerno • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC